Biopreservation Market Size, Share, Global Industry Overview, Trends and Forecast 2026-2034

According to IMARC Group, the global Biopreservation Market size reached USD 9.3 Billion in 2025 and is projected to reach USD 21.8 Billion by 2034, expanding at a CAGR of 9.58% during 2026-2034. This strong Biopreservation Market Growth trajectory reflects the increasing complexity and diversification of biological research applications, rising investments in R&D, and the rapid expansion of the global biopharmaceutical industry.

Biopreservation Industry Overview:

Biopreservation refers to the process of preserving biological materials - such as cells, tissues, organs, and biomolecules - in a viable and functional state for extended periods. The goal is to maintain the integrity, viability, and functionality of biological materials, enabling their storage, transportation, and utilization across research, clinical, and industrial applications.

The biopreservation industry encompasses a wide range of products and techniques designed to support diverse end-use scenarios:

• Cryopreservation: Freezing biological materials at ultra-low temperatures using specialized equipment and cryoprotectant media
• Vitrification: Rapid cooling technique that prevents ice crystal formation in cells and tissues
• Lyophilization (Freeze-Drying): Removal of water under low pressure to preserve biological samples long-term
• Chemical Preservation: Use of fixatives and stabilizers to maintain sample integrity

Key product categories include biopreservation equipment (controlled-rate freezers, cryogenic storage systems, automated biobanking platforms) and biopreservation media (cryoprotectants, osmotic agents, antioxidant formulations). These solutions are adopted across therapeutic development, biobanking, drug discovery, regenerative medicine, and clinical diagnostics.

Global Biopreservation Market Size & Industry Statistics:

Below are the key Biopreservation Market Share and size statistics drawn from IMARC Group's comprehensive market analysis:

Base Year - 2025
Historical Period - 2020-2025
Forecast Period - 2026-2034
Market Size in 2025 - USD 9.3 Billion
Market Forecast in 2034 - USD 21.8 Billion
Market Growth Rate (2026-2034) - 9.58% CAGR
Largest Region - North America

Request for a Sample Report for Detailed Market Insights Evaluation: https://www.imarcgroup.com/biopreservation-market/requestsample

Key Biopreservation Market Trends & Growth Drivers in 2026:

Several powerful forces are shaping Biopreservation Market Trends and fueling robust growth expectations across global life sciences markets:

1. Increasing Demand for Biobanking:

Biobanks are specialized repositories that store diverse biological samples - including cells, tissues, blood, DNA, and other biomaterials - for research and diagnostic purposes. The growing need for large-scale population-based studies, clinical trials, and genomics research projects requiring access to diverse and well-preserved samples is significantly influencing global biobank expansion. Additionally, the rising focus on precision medicine and personalized healthcare has amplified biobank importance, as these facilities provide comprehensive sample collections used for genomic testing, biomarker discovery, and tailored treatment development.

2. Continual Advancements in Regenerative Medicine:

Regenerative medicine - which aims to restore or replace damaged tissues and organs using cell-based therapies and tissue engineering - is a critical driver of Biopreservation Market Growth. Biopreservation plays an essential role in maintaining the viability and potency of stem cells during storage and transportation, with cryopreservation methods such as freezing and vitrification commonly employed. Advancements in stem cell preservation protocols and cryoprotectant formulations have significantly enhanced post-thaw viability and functionality, directly fueling market demand.

3. Expansion of the Biopharmaceutical Industry:

The biopharmaceutical sector - encompassing therapeutic proteins, antibodies, vaccines, and cell-based therapies - relies heavily on biopreservation to ensure the stability, quality, and integrity of biological drug products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions such as temperature, light, and moisture, the demand for cryopreservation, lyophilization, and other preservation methods has grown substantially. This expansion continues to create a strong and sustained demand for biopreservation technologies and solutions worldwide.

4. Growing Focus on Personalized Medicine:

The global shift toward personalized medicine - which tailors medical treatments to individual patients based on genetic and biological characteristics - is generating substantial demand for biopreservation. Preserving patient-specific biological samples for genomic testing, biomarker discovery, and the development of individualized therapies requires robust and reliable biopreservation infrastructure, creating long-term structural demand.

5. Rising Awareness and Research on Rare Diseases:

The growing understanding of rare diseases and genetic disorders among the scientific community has led to increasing needs to preserve biological samples from affected individuals. Biopreservation techniques support the collection and long-term storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating targeted therapy development - directly contributing to market expansion.

6. Technological Advancements in Preservation Methods:

The development of improved cryoprotectants, automated biobanking systems, large-capacity controlled-rate freezers, and enhanced storage protocols is expanding the capabilities and applications of biopreservation. These innovations improve the efficiency, reliability, and safety of preserved biological materials, enabling more widespread adoption across academic, clinical, and commercial settings.

Key Biopreservation Market Segmentation:

By Product Type

Biopreservation Equipment - Largest Segment

Biopreservation equipment dominates the global market due to its essential role in preserving and storing biological materials at optimal conditions. This category encompasses specialized devices including controlled-rate freezers, cryogenic storage tanks, automated biobanking systems, lyophilizers, and vitrification systems. Equipment manufacturers adhere to strict quality and regulatory standards to ensure reliability and safety of their products. The increasing demand for biobanking, regenerative medicine, and drug discovery activities - underpinned by advancements in genomics and personalized medicine - continues to fuel equipment demand globally.

Biopreservation Media:

Biopreservation media - also known as cryopreservation or storage media - are specially formulated solutions designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain cryoprotectants, osmotic agents, antioxidants, and nutrients that help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.

By Application:

Biobank Applications - Largest Market Share

Biobank applications account for the largest Biopreservation Market Share as these specialized facilities store and manage large collections of biological samples for research, clinical, or diagnostic purposes. Biobank facilities often participate in collaborative multi-center research initiatives, requiring effective techniques to ensure the compatibility, integrity, and viability of samples during transportation and exchange. The rapid growth of national and international biobanking programs is a primary driver of this segment's dominance.

Therapeutic Applications

Therapeutic applications of biopreservation - including the preservation of stem cells, immune cells, and engineered tissue constructs for clinical use - represent a rapidly growing segment. Cell-based therapies for conditions such as cancer, autoimmune diseases, and degenerative disorders require reliable preservation infrastructure to maintain therapeutic viability from manufacturing through patient administration.

Drug Discovery Applications:

Drug discovery applications play a significant role in driving demand for biopreservation technologies. Cell lines and primary cells used for screening, testing, and studying the efficacy and safety of potential drug candidates must be preserved with high accuracy and efficiency. Biopreservation technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS), accelerating the drug discovery process.

Regional Biopreservation Market Analysis

North America - Largest: United States & Canada; well-established healthcare infrastructure, advanced research institutions, pharmaceutical companies, biotechnology firms, robust biobank networks, and strong government-funded biopreservation initiatives.

Europe: Germany, France, UK, Italy, Spain; mature healthcare systems, growing demand for regenerative medicine and cell therapies, supportive digital health and bioscience policies.

Asia Pacific: China, Japan, India, South Korea, Australia; rapidly expanding biopharmaceutical industry, large population and healthcare needs, growing focus on personalized medicine.

Latin America: Brazil, Mexico; Brazil leads LatAm healthcare market, growing biopharmaceutical investments and clinical trial activity driving demand for biopreservation solutions.

Middle East & Africa: UAE, Saudi Arabia, South Africa; healthcare modernization, rising chronic disease burden, growing medical tourism, and expanding biotechnology research infrastructure.

Connect for Detailed Segmentation Analysis - Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=829&flag=C

Leading Players in the Biopreservation Industry:

The global biopreservation market features an established set of specialized life sciences companies and diversified healthcare technology leaders. Top companies recognize the growing demand for biobanking services, regenerative medicine applications, and biopharmaceutical production, and are investing heavily in innovation, capacity expansion, and strategic partnerships.

Key companies covered in the IMARC Group report include:

• BioLife Solutions, Inc.
• Thermo Fisher Scientific Inc.
• VWR International, LLC
• Panasonic Corporation
• BioCision LLC

The report includes comprehensive competitive analysis covering market structure, player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant.

Latest Biopreservation Industry Developments:

June 2023 - BioLife Solutions, Inc.:

BioLife Solutions, Inc. introduced a new, large-capacity controlled-rate freezer (CRF) to expand its CRF product line. This product enables the company to support autologous and allogeneic cell and gene therapy (CGT) customers at commercial-scale manufacturing, fulfilling a critical industry need for high-volume cell therapy preservation capabilities.

January 2023 - Thermo Fisher Scientific Inc.:

Thermo Fisher Scientific Inc. completed its acquisition of The Binding Site Group, a global leader in specialty diagnostics, for an undisclosed sum. The acquisition aimed to expand Thermo Fisher's specialty diagnostics portfolio and incorporate pioneering innovation in diagnostics and monitoring for multiple myeloma, further strengthening its position in the life sciences market.

2023 - PHC Holdings Corporation:

PHC Holdings Corporation announced its acquisition of the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd., making SciMed a wholly owned subsidiary. This acquisition was designed to expand the company's life sciences business footprint across the Asia-Pacific region, reflecting the growing importance of biopreservation in Asia Pacific markets.

About Us:

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Technology, Construction, Healthcare, Energy, Food & Beverages, and more.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302

This release was published on openPR.